-
$60.00 – $210.00Price range: $60.00 through $210.00
5-AMINO-1MQ is a metabolic enzyme-modulation category product associated with NNMT pathway activity, cellular energy balance, and adipose-metabolism signaling. It gives clinics a differentiated option outside GLP-1, amylin, and GH-axis product categories.
Professional use only. Intended for licensed provider evaluation, formulary planning, and provider-directed protocols.
-
$90.00
CJC-1295 w/DAC is a long-acting GHRH analog category product positioned for sustained GH-axis signaling. The DAC modification is commonly used to differentiate it from shorter-acting CJC-1295 formats and from ghrelin-receptor secretagogues.
Professional use only. Intended for licensed provider evaluation, formulary planning, and provider-directed protocols.
-
$33.00 – $53.00Price range: $33.00 through $53.00
GHRP-2 is a growth hormone secretagogue category product associated with ghrelin receptor pathway activation and robust GH-axis signaling. It is commonly positioned for providers comparing classic GHRP activity with more selective options such as Ipamorelin.
Professional use only. Intended for licensed provider evaluation, formulary planning, and provider-directed protocols.
-
$33.00 – $53.00Price range: $33.00 through $53.00
GHRP-6 is a classic growth hormone secretagogue associated with ghrelin receptor pathway activity and appetite-linked physiology. It is commonly positioned for providers comparing traditional GHRPs against more selective GH-axis options.
Professional use only. Intended for licensed provider evaluation, formulary planning, and provider-directed protocols.
-
$38.00
Hexarelin is a potent growth hormone secretagogue known for strong ghrelin receptor activity and a robust GH-axis signaling profile. It is commonly differentiated from more selective secretagogues by its broader endocrine engagement.
Professional use only. Intended for licensed provider evaluation, formulary planning, and provider-directed protocols.
-
$72.00
IGF-1 LR3 is a long-acting IGF-1 analog category product associated with growth-factor signaling, nutrient-partitioning pathways, and cellular recovery biology. It is distinct from GH secretagogues because it acts downstream of the GH-axis rather than stimulating pituitary GH release.
Professional use only. Intended for licensed provider evaluation, formulary planning, and provider-directed protocols.
-
$45.00
MGF is an IGF-1 splice-variant peptide associated with localized growth-factor signaling, tissue adaptation, and mechanical-stress response pathways. It is distinct from systemic GH secretagogues and broader endocrine-focused formulations.
Professional use only. Intended for licensed provider evaluation, formulary planning, and provider-directed protocols.
-
$40.00
PEG MGF is a pegylated MGF category product positioned for extended localized growth-factor pathway support. It builds on the MGF concept while offering a longer-exposure profile for providers evaluating tissue-adaptation and recovery-support categories.
Professional use only. Intended for licensed provider evaluation, formulary planning, and provider-directed protocols.
-
$50.00 – $70.00Price range: $50.00 through $70.00
Sermorelin is a GHRH analog category product commonly used in provider-directed hormone optimization and recovery-support protocols. It supports a physiologic upstream GH-axis narrative by acting at the pituitary GHRH receptor level.
Professional use only. Intended for licensed provider evaluation, formulary planning, and provider-directed protocols.
-
$60.00
SLU-PP-332 is an advanced metabolic signaling compound associated with exercise-mimetic energy pathways, mitochondrial activity, oxidative metabolism, and cellular energy utilization. It is not a peptide hormone, GLP-1, or growth hormone secretagogue.
Professional use only. Intended for licensed provider evaluation, formulary planning, and provider-directed protocols.
-
$78.00
Tesamorelin | Ipamorelin is a dual-pathway GH-axis blend combining a GHRH analog with a selective ghrelin receptor agonist. It is commonly positioned for provider-directed protocols requiring both pituitary GHRH signaling and pulsatile GH secretagogue activity.
Professional use only. Intended for licensed provider evaluation, formulary planning, and provider-directed protocols.
